Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Systematic review with pooled analysis of 37 cohort studies characterizing ICI-induced arthritis epidemiology, phenotypes, and management; confirms and refines understanding of a known adverse event but does not establish new clinical outcomes or change practice acutely.
A narrative review synthesizing current surgical management options for recurrent brain metastases, offering clinical recommendations but not reporting original efficacy data or comparative outcomes.
Single-center retrospective cohort of 30 patients with exploratory survival analysis and no validated selection algorithm; identifies associations rather than establishing causal effects or practice-changing thresholds.
Single-center retrospective study of moderate-dose SBRT in a selected population unfit for standard therapy; favorable local control and safety observed but limited by retrospective design, single institution, and modest sample size requiring confirmation.
A narrative review synthesizing current evidence and proposing future research priorities for survivorship care in oligometastatic disease, without reporting original trial data or novel empirical findings.
Retrospective cohort study with clear stratification and identified prognostic factors in radioiodine-refractory DTC, but limited by single-centre design, modest sample size, and surrogate endpoint assessment in the non-refractory group.